Affy to Collaborate with Qiagen/BD Joint Venture on Whole Blood Expression Profiling | GenomeWeb

NEW YORK, Oct. 31 (GenomeWeb News) - Affymetrix and Hombrechtikon, Switzerland-based PreAnalytix said today that they have decided to collaborate to use PreAnalytix's Blood RNA System with Affy's GeneChip arrays to analyze whole blood for expression profiling. PreAnalytix is a joint venture between Qiagen and BD.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.